Back to search

National and Kapodistrian University of Athens

Συσχέτιση των επιπέδων οστεοποντίνης και οστεοπροτεγερίνης με τη λειτουργικότητα των αγγείων σε ασθενείς με στεφανιαία νόσο

Abstract

dc:description

Purpose: Osteopontin (OPN) and osteoprotegerin (OPG) are bone metabolism biomarkers which have recently emerged as key factors in both vascular remodeling and atherosclerosis progression. Interleukin-6 (IL-6) is an inflammatory cytokine with a key role in the development of atherosclerosis. Endothelial function and arterial stiffness are key players in the pathophysiology of atherosclerotic disease and their measurement is well validated in large population studies as strong predictor of adverse cardiovascular outcomes. Our purpose is to evaluate the relationship of OPN and OPG with vascular function (endothelial function and arterial stiffness) and the severity of coronary artery disease (CAD) in patients with CAD. Methods: The study population consisted of 437 subjects undergoing diagnostic coronary angiography for suspected CAD. Subjects were angiographically categorized in the group of CAD: 308 patients (mean aged 60±11years), and control group: 129 healthy subjects (mean aged 59±13 years). Gensini score was used to evaluate the severity of CAD based on the narrowing of the lumen diameter, the site and the numbers of the stenotic vessels, with greater values representing extensive CAD. Serum/plasma OPN and OPG levels were measured using ELISA. Carotid-femoral pulse wave velocity (PWV) was measured as an index of aortic stiffness. Endothelial function was evaluated by flow mediated dilation (FMD) and endothelium – independent dilation (EID) in the brachial artery. In a subpopulation of our study (331 patients - 219 patients and 112 healthy subjects), serum interleukin-6 (IL-6) levels were also measured using ELISA. Results: There was no significant difference between control subjects and CAD patients according to age (P=0.13), serum creatinine levels (Ρ=0.53) and smokers percentage (P=0.44). Compared to control subjects, CAD patients had higher levels of logOPG (Ρ<0.001) and higher levels of logOPN (Ρ<0.001). CAD patients had also significantly impaired PWV (Ρ=0.009) and impaired FMD (Ρ<0.001). There was no significant difference in EID (Ρ=0.27) between CAD patients and control subjects. Moreover, logOPG levels (Ρ<0.001), logOPN levels (Ρ<0.001), PWV (Ρ=0,016) and FMD (P<0.001) were associated with the severity of CAD as it could be calculated with the number of affected coronary vessels. Notably, there was a significant association between the number of affected coronary vessels and the severity of CAD as it could be calculated with Gensini score (Ρ<0.001). Multivariate linear regression analysis revealed that increased logOPG (P=0.013) and logOPN (P=0.006) levels were associated with 3‐vessel CAD patients, independently of other known cardiovascular risk factors. Simiratly, multivariate linear regression analysis revealed that logOPG and logOPG levels were associated with the severity of CAD as it could be calculated with Gensini score (Ρ=0.04 for OPG and Ρ=0.09 for OPN- there was a statistical trend for OPN), independently of other known cardiovascular risk factors. Additionally, in CAD patients, PWV was positively associated with logOPG levels (r=0.13, Ρ=0.04) and logOPN levels (r=0.10 Ρ=0.049). Multivariate linear regression analysis revealed that logOPG levels were associated with PWV (P=0.001), thus a statistical trend (P=0.056) revealed that logOPN levels were associated with PWV (P=0.056). Moreover, in CAD patients, FMD was negatively associated with logOPG levels (r=-0.11, P=0.05). Multivariate linear regression analysis revealed that FMD was negatively associated with logOPG levels (P=0.04), independently of other possible confounders Regarding the subpopulation of our study, compared to control subjects, CAD patients had higher levels of logIL-6 (Ρ=0.03). Importantly, in CAD patients logIL-6 levels were positively associated with logOPG (r=0.17, P=0.01) and logOPN (r=0.30, P<0.001) levels. Additionally, in CAD patients, PWV was positively associated with logIL-6 levels (r=0.17, Ρ=0.02). Conclusion: CAD patients have increased OPG, OPN and IL-6 levels. The present study revealed there is a consistent association between OPG and OPN serum levels, vascular function and inflammation in CAD patients. Furthermore, we found that OPG and OPN serum levels are positively associated with the severity of CAD. These findings suggest another possible mechanism linking OPG and OPN serum levels with CAD progression through arterial wall stiffening and inflammation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Maniatis, Konstantinos
  • Μανιάτης, Κωνσταντίνος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47627

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Maniatis, Konstantinos; Μανιάτης, Κωνσταντίνος. Συσχέτιση των επιπέδων οστεοποντίνης και οστεοπροτεγερίνης με τη λειτουργικότητα των αγγείων σε ασθενείς με στεφανιαία νόσο. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/47627